Determination of the biological activity and structure activity relationships of drugs based on the highly cytotoxic duocarmycins and CC-1065

The natural Antibiotics CC‑1065 and the Duocarmycins are highly cytotoxic compounds which however are not suitable for Cancer therapy due to their general toxicity. We have developed glycosidic prodrugs of seco-analogues of these Antibiotics for a selective Cancer therapy using conjugates of glycohydrolases and tumour-selective monoclonal Antibodies for the liberation of the drugs from the prodrugs predominantly at the tumour site. For the determination of structure activity relationships of the different seco-drugs, experiments addressing their interaction with synthetic DNA were performed. Using electro-spray mass spectrometry and high performance liquid chromatography, the experiments revealed a correlation of the stability of these drugs with their cytotoxicity in Cell Culture investigations. Furthermore, it was shown that the drugs bind to AT-rich regions of double-stranded DNA and the more cytotoxic drugs induce DNA fragmentation at room temperature in several of the selected DNA double-strands. Finally, an explanation for the very high cytotoxicity of CC-1065, the Duocarmycins and analogous drugs is given.

ADEPT; CC-1065; DNA alkylation; HPLC; anticancer agents; cancer therapy; cytotoxicity; duocarmycins; electrospray mass spectrometry; oligonucleotides; structure activity relationship.